Welcome to our dedicated page for Celestica SEC filings (Ticker: CLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Celestica’s 10-K runs hundreds of pages, packed with ATS versus CCS revenue splits, aerospace contract milestones, and intricate supply-chain risk factors. Finding segment margins or tracking when executives trade around server platform launches can feel like looking for a diode on a crowded PCB.
Stock Titan solves that problem. Our AI reads every line the moment it hits EDGAR, turning Celestica SEC filings explained simply from wishful thinking into reality. Need the Celestica quarterly earnings report 10-Q filing? You’ll see key backlog shifts and capital-equipment demand in seconds. Curious about a sudden management trade? Receive alerts on Celestica Form 4 insider transactions real-time and review concise tables summarizing each deal.
Here’s what you’ll uncover faster than scrolling a single PDF:
- Celestica insider trading Form 4 transactions that spotlight confidence—or caution—before major defense orders.
- AI-driven Celestica earnings report filing analysis comparing ATS gross margin to prior quarters.
- Clear guidance for understanding Celestica SEC documents with AI, including glossary links for complex supply-chain terms.
- Celestica annual report 10-K simplified with segment performance visuals you can export.
- Drill-downs into the Celestica proxy statement executive compensation to benchmark incentive metrics.
- Instant summaries of Celestica 8-K material events explained, from factory expansions to cloud-server design wins.
Whether you monitor Celestica executive stock transactions Form 4 for sentiment shifts or compare quarterly cash flows, Stock Titan’s real-time updates and plain-English insights turn complex disclosures into actionable knowledge.
Celestica Inc. Chief Financial Officer insider activity shows routine equity compensation events reported on a Form 4. On 12/01/2025, the CFO acquired 20,408 common shares through the vesting and settlement of previously granted restricted share units at an exercise price of $0. On the same date, 10,925 common shares were disposed of at $344.41 per share to cover tax withholding obligations arising from the RSU vesting, leaving the reporting person with 9,483 common shares held directly.
The derivative table shows 20,408 restricted share units exercised into common shares, reducing the reporting person’s RSU balance to zero for that grant. The filing notes that each RSU represents a contingent right to receive one common share or an equivalent cash amount, and that the original grant of 61,224 RSUs from 01/31/2023 vests in three installments over a three-year period.
Celestica Inc.'s Chief Human Resources Officer reported several equity transactions in company common shares on 12/01/2025. The officer acquired 6,802 common shares at an exercise price of $0 through the vesting and settlement of restricted share units (RSUs), increasing directly held shares before subsequent transactions.
To cover tax withholding arising from the RSU vesting, 3,642 shares were withheld and disposed of at $323.38 per share, and an additional 3,160 shares were sold at the same price. After these transactions, the officer directly owned 13,892 common shares and held no remaining RSUs from this grant.
Celestica Inc. reported an insider equity transaction by its President. On 12/01/2025, the officer acquired 17,792 common shares through the vesting and settlement of restricted share units at an exercise price of $0, increasing directly held shares. On the same date, 8,248 common shares were disposed of at $344.41 per share to cover tax withholding obligations tied to the RSU vesting. Following these transactions, the officer directly owned 108,970 common shares. The underlying RSU award covered 17,792 common shares and was fully settled, leaving no derivative securities from that grant outstanding.
Celestica Inc. Chief Operations Officer reports RSU vesting, tax withholding, and share sale. On 12/01/2025, 17,792 common shares were acquired at an exercise price of $0 upon the vesting and settlement of restricted share units (RSUs). On the same date, 8,605 of these shares were disposed of at $323.38 per share to cover tax withholding obligations, and 9,187 shares were sold in a market transaction at $323.38 per share, leaving 0 common shares held directly after these transactions.
These activities relate to an RSU grant of 53,375 units awarded on January 31, 2023, which vests ratably over three years, including on December 1 following the second anniversary of the grant date. Each RSU represents a contingent right to receive one common share or an equivalent cash amount at the holder’s election.
Celestica Inc. insider plans to sell common shares under Rule 144. A notice reports a proposed sale of 3,160 common shares through broker Canaccord Genuity on the NYSE, with an aggregate market value of 1,088,335.60. The filing notes that 115,036,621 shares of the issuer were outstanding. The shares to be sold were acquired on 12/01/2025 through the vesting of restricted share units from Celestica Inc., with the same date listed for acquisition and payment.
Celestica Inc. insider filed a Form 144 notice to sell up to 9,186 common shares through broker Canaccord Genuity on the NYSE, with an approximate sale date of 12/01/2025. The filing lists an aggregate market value of these shares of $3,163,750.26. The 9,186 shares were acquired on 12/01/2025 through restricted share unit vesting from Celestica Inc. Shares outstanding were 115,036,621 at the time referenced, providing context for the size of this planned sale.
Celestica (CLS) reported a director’s open‑market purchases on 10/30/2025. The filing lists four buy transactions totaling 6,000 common shares, at weighted average prices of $339.68 (700 shares), $340.55 (600), $341.96 (3,227), and $342.44 (1,473). Following these trades, the director beneficially owns 6,000 shares, held directly. No derivative securities were reported.
Celestica Inc. (CLS) announced final acceptance from the Toronto Stock Exchange for a normal course issuer bid to repurchase up to 5,722,527 common shares, representing approximately 5 percent of the outstanding public float as of October 20, 2025. The NCIB will run from November 3, 2025 to November 2, 2026. The company furnished the related press release as Exhibit 99.1.
Celestica Inc. (CLS) — Form 3 initial ownership filing
A newly reported director filed a Form 3 reflecting their status under Section 16. As of the event date 10/27/2025, the filing states no securities are beneficially owned. The form was submitted by an attorney‑in‑fact pursuant to a Power of Attorney (Exhibit 24.1) and indicates it was filed by one reporting person.
Celestica Inc. (CLS) appointed Laurette T. Koellner to its Board of Directors, effective October 27, 2025. The Board determined she is an independent director under Canadian securities laws and NYSE listing standards.
Koellner will serve on the Audit, Human Resources and Compensation, and Nominating and Corporate Governance committees. She previously served on Celestica’s Board before stepping down in January 2025 and returns with senior leadership experience at International Lease Finance Corporation and The Boeing Company. She will be compensated according to existing Board director policies.
FAQ
What is the current stock price of Celestica (CLS)?
What is the market cap of Celestica (CLS)?
